Tokyo - Delayed Quote • JPY
ReproCELL Incorporated (4978.T)
At close: April 26 at 3:15 PM GMT+9
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
2,506,758.00
2,953,271.00
2,234,568.00
1,286,283.00
Cost of Revenue
1,415,095.00
1,812,024.00
1,431,129.00
803,582.00
Gross Profit
1,091,664.00
1,141,247.00
803,438.00
482,700.00
Operating Expense
1,529,953.00
1,497,471.00
1,450,564.00
1,530,747.00
Operating Income
-438,289.00
-356,224.00
-647,126.00
-1,048,047.00
Net Non Operating Interest Income Expense
50,281.00
43,387.00
8,840.00
3,048.00
Pretax Income
-217,259.00
-303,662.00
-573,944.00
-811,937.00
Tax Provision
228.00
1,650.00
1,361.00
1,680.00
Net Income Common Stockholders
-217,489.00
-305,313.00
-575,094.00
-812,572.00
Diluted NI Available to Com Stockholders
-217,489.00
-305,313.00
-575,094.00
-812,572.00
Basic EPS
-2.58
-3.62
-7.57
-11.38
Diluted EPS
-2.58
-3.62
-7.57
-11.38
Basic Average Shares
85,045.99
84,230.00
75,949.00
71,432.00
Diluted Average Shares
85,068.94
84,230.00
75,949.00
71,432.00
Total Operating Income as Reported
-438,289.00
-356,224.00
-647,127.00
-1,048,046.00
Total Expenses
2,945,048.00
3,309,495.00
2,881,693.00
2,334,329.00
Net Income from Continuing & Discontinued Operation
-217,489.00
-305,313.00
-575,094.00
-812,572.00
Normalized Income
-93,168.23
-198,891.24
-517,143.79
-823,608.28
Interest Income
50,281.00
43,467.00
9,182.00
3,367.00
Interest Expense
--
80.00
342.00
319.00
Net Interest Income
50,281.00
43,387.00
8,840.00
3,048.00
EBIT
-217,259.00
-303,582.00
-573,602.00
-811,618.00
EBITDA
-217,259.00
-254,588.00
-513,849.00
-750,118.00
Reconciled Cost of Revenue
1,415,095.00
1,812,024.00
1,431,129.00
803,582.00
Reconciled Depreciation
--
48,994.00
59,753.00
61,500.00
Net Income from Continuing Operation Net Minority Interest
-217,489.00
-305,313.00
-575,094.00
-812,572.00
Total Unusual Items Excluding Goodwill
-161,876.00
-138,570.00
-75,456.00
15,907.00
Total Unusual Items
-161,876.00
-138,570.00
-75,456.00
15,907.00
Normalized EBITDA
-55,383.00
-116,018.00
-438,393.00
-766,025.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-37,555.23
-32,148.24
-17,505.79
4,870.72
3/31/2021 - 6/26/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4884.T Kringle Pharma, Inc.
545.00
-3.37%
4896.T K Pharma,Inc.
623.00
+2.64%
6190.T PhoenixBio Co., Ltd.
479.00
-0.21%
4881.T FunPep Company Limited
146.00
-1.35%
6794.TWO UnicoCell Biomed Co., Ltd.
88.60
+2.67%
4891.T TMS Co., Ltd.
236.00
-0.42%
7096.T StemCell Institute Inc.
1,843.00
-1.71%
4894.T Cuorips Inc.
3,325.00
+0.45%
4888.T Stella Pharma Corporation
292.00
+0.69%
4875.T MediciNova, Inc.
206.00
-1.90%